Table 2 Concentrations (ng/mL) of the most prevalent PFASs in cord plasma samples of this study population

 N > LOD (%)

687 (100)

686 (99.9)

687 (100)

681 (99.1)

686 (99.9)

621 (90.4)

687 (100)

668 (97.2)

 Range

0.39–65.61

<LOD–29.97

0.18–3.29

<LOD–5.73

<LOD–5.27

<LOD–1.14

0.05–0.85

<LOD–0.46

 Mean (SD)

2.93 (3.11)

7.73 (3.98)

0.70 (0.29)

0.45 (0.42)

0.46 (0.34)

0.10 (0.07)

0.18 (0.08)

0.05 (0.03)

 Median

2.48

6.98

0.64

0.36

0.4

0.09

0.16

0.05

 N > LOD (%)

328 (100)

328 (100)

328 (100)

324 (98.8)

327 (99.7)

291 (88.7)

328 (100)

318 (97.0)

 Range

0.39–18.68

0.70–29.97

0.18–3.29

<LOD–2.51

<LOD–2.60

<LOD–0.51

0.07–0.78

<LOD–0.39

 Mean (SD)

2.81 (1.86)

7.57 (3.71)

0.71 (0.31)

0.44 (0.32)

0.45 (0.26)

0.11 (0.05)

0.17 (0.08)

0.05 (0.03)

 Median

2.47

7

0.66

0.38

0.41

0.1

0.16

0.05

 N > LOD (%)

357 (100)

356 (99.7)

357 (100)

355 (99.4)

357 (100)

328 (91.9)

359 (100)

348 (97.5)

 Range

0.62–65.61

<LOD–25.99

0.18–2.04

<LOD–5.73

0.05–5.27

<LOD–1.14

0.05–0.85

<LOD–0.46

 Mean (SD)

3.04 (3.93)

7.86 (4.22)

0.69 (0.28)

0.45 (0.50)

0.46 (0.40)

0.10 (0.08)

0.18 (0.08)

0.05 (0.03)

 Median

2.49

6.89

0.64

0.35

0.39

0.09

0.16

0.05